Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Men can experience female pattern hair loss, needing different treatments.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Minoxidil and spironolactone slow hair loss in women.

Minoxidil is cost-effective for regrowing hair on the scalp's top but not the front, requiring ongoing use.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

The procedure effectively created natural-looking hairlines and improved facial balance in female patients.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

Mutations in the WNT10A gene cause Short Anagen Hair syndrome and increase the risk of male pattern hair loss.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Low-cost dermoscopes can effectively diagnose early female pattern hair loss.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.